Loading stock data…
$126.22-0.84 (-0.66%)
Constellation Brands, Inc., together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy.
Constellation Brands, Inc. in the Consumer Defensive sector is trading at $126.22 with a market capitalization of $23.2B. Wall Street consensus targets $151.74 (23 analysts), implying a +20.2% move over the next 12 months. The stock is currently 25% below its 52-week high of $168.60, remaining 10.6% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. Risk note: RSI 82 is overbought against a weak tape. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.43B↑ | $1.92B↓ | $2.22B↓ | $2.48B↓ | $2.52B |
| Gross Profit | $1.32B↑ | $951.70M↓ | $1.18B↓ | $1.31B↑ | $1.27B |
| Operating Income | $863.60M↑ | $531.20M↓ | $692.00M↓ | $874.00M↑ | $765.90M |
| Net Income | $653.80M↑ | $201.80M↓ | $502.80M↑ | $466.00M↓ | $516.10M |
Constellation Brands, Inc., together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy. It offers beer under the Corona Extra, Corona Familiar, Corona Sun...
Academic risk and quality models computed from STZ's own filings and price history, not from analyst opinion.
Mixed: 6 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z in the 1.81 to 2.99 grey zone, the band where the model gives no clear bankruptcy verdict.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, level with the current 31.7% reading.
Fama-French 5-factor market beta. The five factors explain 15% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-10-13.